Large-scale study finds genetic testing technology falsely detects very rare variants

A technology that is widely used by commercial genetic testing companies is “extremely unreliable” in detecting very rare variants, meaning results suggesting individuals carry rare disease-causing genetic variants are usually wrong, according to new research published in the BMJ. After hearing of cases where women had surgery scheduled after wrongly being told they had very…

Details

Cheap, potent pathway to pandemic therapeutics

PITTSBURGH, Feb. 15, 2021 – By capitalizing on a convergence of chemical, biological and artificial intelligence advances, University of Pittsburgh School of Medicine scientists have developed an unusually fast and efficient method for discovering tiny antibody fragments with big potential for development into therapeutics against deadly diseases. The technique, published today in the journal Cell…

Details

Existing heart failure drug may treat potential COVID-19 long-hauler symptom

In a new study out of University of California San Diego School of Medicine, researchers found a drug used for heart failure improves symptoms associated with postural orthostatic tachycardia syndrome, otherwise known as POTS. This complex, debilitating disorder affects the body’s autonomic nervous system, causing a high heart rate, usually when standing. Writing in the…

Details

Hindawi and Maverick announce open access publishing services collaboration

Maverick Publishing Specialists and Hindawi Limited have recently entered into an open access publishing collaboration whereby a dedicated team of Maverick specialists and Hindawi’s Publishing Partnerships business division will work collaboratively to broaden awareness of Hindawi’s range of publishing services amongst journal publishers. Hindawi’s publishing partnerships services, built upon its open source journal management platform,…

Details